Announcements Trials
Browse Landscape

Phase

Phase NA 26Phase 2 7Phase 4 3Phase 3 3Phase EARLY_PHASE1 2Phase 2/3 1

Status

Completed 23Recruiting 17Terminated 7Active not recruiting 7Withdrawn 5Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Recurrence 1Neoplasms 1Glioblastoma 1

Interventions

fludarabine 17Cyclophosphamide 16Positron Emission Tomography Computed Tomography 4Oncolytic Virotherapy 4Metformin 468Ga-pentixafor 4lenvatinib 3Radiosurgery 3Pemetrexed 3Paclitaxel 3Melphalan 3Immunotherapy, Adoptive 3Gemcitabine 3Cholestanetriol 26-Monooxygenase 3Carboplatin 368Ga-NOTA-RM26 3toripalimab 2sintilimab 2pembrolizumab 2gallium Ga 68 dotatate 2gallium 68 PSMA-11 2fludarabine phosphate 2alpha-Synuclein 2Progesterone 2Nivolumab 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Influenza Vaccines 2Fluorodeoxyglucose F18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Magnetic Resonance Spectroscopy × Clear all
NCT04721756 2022-04-25

Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

Avid Radiopharmaceuticals

Phase EARLY_PHASE1 Unknown
30 enrolled
Tumor-Agnostic

Neoplasms

NCT04315584 2020-03-24

FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

University of Virginia

Phase EARLY_PHASE1 Unknown
5 enrolled
CNS

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡